Blood marker tracks hidden progression in multiple sclerosis

AI Summary

Researchers from the University of Basel have identified a blood marker that could help track the progression of multiple sclerosis (MS) more accurately. This advancement may improve monitoring and treatment response for patients facing gradual disability progression despite modern therapies.

Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a substantial proportion of patients, even in the absence of relapses. Detecting and treating this gradual worsening of disability remains one of the greatest challenges in MS care. Researchers from the University of Basel, Switzerland, now report on a blood marker that could help track disease progression and monitor treatment response.